Dopamine receptor-interacting proteins: The Ca2+ connection in dopamine signaling

Clare Bergson, Robert Levenson, Patricia S. Goldman-Rakic, Michael S. Lidow

Research output: Contribution to journalReview article

144 Scopus citations

Abstract

Abnormal activity of the dopamine system has been implicated in several psychiatric and neurological illnesses; however, lack of knowledge about the precise sites of dopamine dysfunction has compromised our ability to improve the efficacy and safety of dopamine-related drugs used in treatment modalities. Recent work suggests that dopamine transmission is regulated via the concerted efforts of a cohort of cytoskeletal, adaptor and signaling proteins called dopamine receptor-interacting proteins (DRIPs). The discovery that two DRIPs, calcyon and neuronal Ca2+ sensor 1 (NCS-1), are upregulated in schizophrenia highlights the possibility that altered protein interactions and defects in Ca2+ homeostasis might contribute to abnormalities in the brain dopamine system in neuropsychiatric diseases.

Original languageEnglish (US)
Pages (from-to)486-492
Number of pages7
JournalTrends in Pharmacological Sciences
Volume24
Issue number9
DOIs
StatePublished - Sep 1 2003

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint Dive into the research topics of 'Dopamine receptor-interacting proteins: The Ca<sup>2+</sup> connection in dopamine signaling'. Together they form a unique fingerprint.

  • Cite this